Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $825.47 billion, total revenue of $173.15 billion and a weighted average PE ratio of 45.98.
Market Cap
825.47B
Revenue
173.15B
Profits
17.95B
PE Ratio
45.98
Profit Margin
10.37%
Dividend Yield
0.21%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 222.97B | -1.75% | 2,695,340 | 46.34B |
| 2 | DHR | Danaher Corporation | 144.27B | -1.17% | 3,272,748 | 25.11B |
| 3 | NTRA | Natera, Inc. | 46.72B | -1.23% | 1,030,198 | 2.71B |
| 4 | IQV | IQVIA Holdings Inc. | 42.67B | -3.20% | 1,381,316 | 16.98B |
| 5 | A | Agilent Technologies, Inc. | 41.40B | -2.66% | 1,603,188 | 7.37B |
| 6 | IDXX | IDEXX Laboratories, Inc. | 40.98B | -2.83% | 610,889 | 4.55B |
| 7 | WAT | Waters Corporation | 39.59B | -1.58% | 419,502 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 31.87B | -3.28% | 1,820,154 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.56B | -1.47% | 151,116 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 26.35B | -0.62% | 615,679 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 25.99B | -0.69% | 728,286 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 21.60B | -0.27% | 2,039,095 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.49B | -0.07% | 185,215 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 14.18B | -2.41% | 1,496,185 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.40B | -2.68% | 729,156 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.22B | -3.95% | 949,581 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.76B | -2.51% | 1,536,461 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 8.03B | 2.68% | 1,805,769 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 5.66B | -2.36% | 448,768 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.31B | -1.64% | 2,024,895 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.67B | -0.33% | 589,873 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.88B | 0.25% | 1,358,547 | 308.08M |
| 23 | GRAL | GRAIL, Inc. | 3.53B | -1.54% | 693,529 | 165.26M |
| 24 | VCYT | Veracyte, Inc. | 3.41B | -0.19% | 962,000 | 561.90M |
| 25 | CDNA | CareDx, Inc. | 2.60B | -1.12% | 934,602 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.56B | -0.14% | 426,646 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.26B | 1.04% | 1,148,398 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.77B | -3.49% | 2,548,522 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.72B | -1.96% | 541,575 | 35.41M |
| 30 | OPK | OPKO Health, Inc. | 1.19B | -3.05% | 2,575,766 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 1.00B | -0.46% | 216,737 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 555.81M | 2.38% | 374,988 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 304.17M | -0.31% | 1,194,468 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 280.98M | 1.72% | 86,392 | 102.94M |
| 35 | XGN | Exagen Inc. | 176.84M | -3.69% | 151,901 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 139.73M | 3.39% | 212,814 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 119.38M | -10.69% | 1,365,036 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 112.95M | -10.68% | 244,634 | 74.58M |
| 39 | MDXH | MDxHealth SA | 68.08M | -4.66% | 329,976 | 114.02M |
| 40 | PRPO | Precipio, Inc. | 48.78M | -0.55% | 304,035 | 27.20M |
| 41 | ADVB | Advanced Biomed Inc. | 14.84M | -3.85% | 39,774 | - |
| 42 | NDRA | ENDRA Life Sciences Inc. | 8.86M | -2.40% | 2,874 | - |
| 43 | XWEL | XWELL, Inc. | 8.22M | -1.86% | 26,767 | 28.28M |
| 44 | BIAF | bioAffinity Technologies, Inc. | 4.82M | -41.52% | 2,411,928 | 5.90M |
| 45 | ISPC | iSpecimen Inc. | 4.00M | 3.25% | 14,179,630 | 466.30K |